Literature DB >> 23486875

Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers.

Anna Jeppsson1, Henrik Zetterberg, Kaj Blennow, Carsten Wikkelsø.   

Abstract

OBJECTIVES: This observational study aimed to explore the pathophysiology of idiopathic normal-pressure hydrocephalus (iNPH) and to evaluate the diagnostic and prognostic value of CSF biomarkers.
METHODS: Lumbar CSF of patients with iNPH and healthy elderly individuals (HI) and ventricular CSF (VCSF) from the patients with iNPH pre and 6 months postsurgery were analyzed by ELISA. We analyzed neurofilament light protein (NFL), myelin basic protein (MBP), a panel of β-amyloid isoforms (Aβ38, Aβ40, and Aβ42), soluble amyloid precursor protein (sAPP) isoforms sAPPα and sAPPβ, total and phosphorylated tau protein (t- and p-tau), and inflammatory markers interleukin 8, interleukin 10, and monocyte chemoattractant protein 1.
RESULTS: NFL was elevated and amyloid precursor protein (APP)-derived proteins and tau proteins were lower in patients with iNPH than in HI. Postsurgery, there was an increase of NFL, APP-derived proteins, p-tau, and albumin in VCSF, whereas levels of MBP and t-tau had decreased. Improved patients showed a greater increase of APP-derived proteins in VCSF following shunting than did those who did not improve.
CONCLUSIONS: We interpret our data as iNPH pathophysiology to be characterized by a reduced periventricular metabolism and axonal degeneration but no major cortical damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486875     DOI: 10.1212/WNL.0b013e31828c2fda

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  59 in total

Review 1.  A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus.

Authors:  Marta Picascia; Roberta Zangaglia; Sara Bernini; Brigida Minafra; Elena Sinforiani; Claudio Pacchetti
Journal:  Funct Neurol       Date:  2015 Oct-Dec

2.  Vascular risk factors in INPH: A prospective case-control study (the INPH-CRasH study).

Authors:  Hanna Israelsson; Bo Carlberg; Carsten Wikkelsö; Katarina Laurell; Babar Kahlon; Göran Leijon; Anders Eklund; Jan Malm
Journal:  Neurology       Date:  2017-01-06       Impact factor: 9.910

3.  Characterization of Cerebrospinal Fluid BACE1 Species.

Authors:  Inmaculada Lopez-Font; Claudia P Boix; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2019-07-09       Impact factor: 5.590

Review 4.  Normal pressure hydrocephalus-an overview of pathophysiological mechanisms and diagnostic procedures.

Authors:  Petr Skalický; Arnošt Mládek; Aleš Vlasák; Patricia De Lacy; Vladimír Beneš; Ondřej Bradáč
Journal:  Neurosurg Rev       Date:  2019-11-08       Impact factor: 3.042

5.  Astroglial activation and altered amyloid metabolism in human repetitive concussion.

Authors:  Pashtun Shahim; Yelverton Tegner; Niklas Marklund; Kina Höglund; Erik Portelius; David L Brody; Kaj Blennow; Henrik Zetterberg
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

6.  Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus.

Authors:  Neill R Graff-Radford
Journal:  Neurology       Date:  2014-10-21       Impact factor: 9.910

7.  Directional diffusion of corticospinal tract supports therapy decisions in idiopathic normal-pressure hydrocephalus.

Authors:  Alina Jurcoane; Fee Keil; Andrea Szelenyi; Waltraud Pfeilschifter; Oliver C Singer; Elke Hattingen
Journal:  Neuroradiology       Date:  2013-10-25       Impact factor: 2.804

Review 8.  Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus.

Authors:  Tommaso Schirinzi; Giulia Maria Sancesario; Giulia Di Lazzaro; Alessio D'Elia; Paola Imbriani; Simona Scalise; Antonio Pisani
Journal:  J Neural Transm (Vienna)       Date:  2018-01-20       Impact factor: 3.575

9.  Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.

Authors:  Henrik Zetterberg; Tobias Skillbäck; Niklas Mattsson; John Q Trojanowski; Erik Portelius; Leslie M Shaw; Michael W Weiner; Kaj Blennow
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

10.  Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition.

Authors:  Jonathan Graff-Radford; Jeffrey L Gunter; David T Jones; Scott A Przybelski; Christopher G Schwarz; John Huston; Val Lowe; Benjamin D Elder; Mary M Machulda; Nathaniel B Gunter; Ronald C Petersen; Kejal Kantarci; Prashanthi Vemuri; Michelle M Mielke; David S Knopman; Neill R Graff-Radford; Clifford R Jack
Journal:  Neurology       Date:  2019-11-12       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.